Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by S100A4 is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. Additionally we are shipping s100a4 Proteins (36) and s100a4 Kits (21) and many more products for this protein.
Showing 10 out of 177 products:
Human Monoclonal s100a4 Primary Antibody for IF, WB - ABIN395081
van Dieck, Lum, Teufel, Fersht: S100 proteins interact with the N-terminal domain of MDM2. in FEBS letters 2010
Show all 5 references for ABIN395081
Human Monoclonal s100a4 Primary Antibody for IF, ELISA - ABIN562767
Nishioku, Furusho, Tomita, Ohishi, Dohgu, Shuto, Yamauchi, Kataoka: Potential role for S100A4 in the disruption of the blood-brain barrier in collagen-induced arthritic mice, an animal model of rheumatoid arthritis. in Neuroscience 2011
Show all 5 references for ABIN562767
Mouse (Murine) Polyclonal s100a4 Primary Antibody for IHC (p), WB - ABIN655727
Miranda, Loeser, Yammani: Sumoylation and nuclear translocation of S100A4 regulate IL-1beta-mediated production of matrix metalloproteinase-13. in The Journal of biological chemistry 2010
Show all 2 references for ABIN655727
Human Polyclonal s100a4 Primary Antibody for IHC, ELISA - ABIN334485
Li, Bresnick: The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. in Cancer research 2006
Show all 2 references for ABIN334485
Human Polyclonal s100a4 Primary Antibody for IHC (p) - ABIN181370
Schäfer, Heizmann: The S100 family of EF-hand calcium-binding proteins: functions and pathology. in Trends in biochemical sciences 1996
Show all 2 references for ABIN181370
Cat (Feline) Polyclonal s100a4 Primary Antibody for IHC (p) - ABIN181369
Ilg, Schäfer, Heizmann: Expression pattern of S100 calcium-binding proteins in human tumors. in International journal of cancer. Journal international du cancer 1996
Show all 2 references for ABIN181369
Human Polyclonal s100a4 Primary Antibody for ELISA, WB - ABIN562766
Chen, Wang, Wu, Su, Hong, Chuang, Chen, Hua, Wu, Cha, Babu, Chen, Lee, Chang, Kuo: CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway. in Journal of cell science 2007
Study shows that negative expression of S100A4 was significantly associated with higher 3-year OS rate and N0 stage for lymph node metastasis in pancreatic neoplasm tumor which suggest that S100A4 expression represents a potential marker for lymph node metastasis and a potential unfavorable factor for prognosis of patients with this disease.
S100A4 mRNA level is an important molecular biomarker for prediction of chemosensitivity to gemcitabine in unresectable pancreatic cancer.
Tag7 (show PGLYRP1 Antibodies)-Mts1 complex causes chemotactic migration of lymphocytes, with NK cells being a preferred target.
our data suggest a novel mechanism for mutant p53V143A accumulation and add a new facet to the role of S100A4 in cancer
S100A4 levels are elevated in human periodontal ligament cells in response to IL-1beta (show IL1B Antibodies).
Enhanced S100A4 expression was observed in remodeled intrapulmonary arteries of COPD patients.
Downregulation of AKT3 (show AKT3 Antibodies) increases migration and metastasis in triple negative breast cancer cells by upregulating S100A4.
vimentin (show VIM Antibodies) and FSP1 have roles in gingival fibrosis
Through selective knockout or inhibition of the network components, we show that the interaction between epidermal growth factor receptor (EGFR (show EGFR Antibodies)) and S100A4 modulates the sensitivity of angiogenesis development to matrix metalloproteinases (MMPs) activity
The results show that S100A4 enhances the activity of matrix metalloproteinases (MMPs), causing higher cell dissociation. Moreover, it leads to an increased stability of the pathological state.
Our results indicated that RNV was ameliorated by Ad-S100A4-RNAi transfer in a mouse model of OIR through mediation of the anti-apoptotic effect of Bcl-2 (show BCL2 Antibodies) by reducing the expression of CREB (show CREB1 Antibodies).
The thymic CD45 (show PTPRC Antibodies)-FSP1+ cells are a subpopulation of fibroblasts, which is crucial for the maintenance and regeneration of thymic epithelial cells.
Enhanced S100A4 expression was observed in remodeled intrapulmonary arteries of mice with smoke-induced emphysema.
S100A4 promotes liver fibrosis by activating HSCs, which may represent a potential target for anti-fibrotic therapies.
The S100A4 blocking antibody (6B12) reduces tumor growth and metastasis in a model of spontaneous breast cancer.
Functional studies of human TH2 cells as well as mouse models of allergy showed that deletion of one of the genes, S100A4, resulted in decreased signs of allergy.
S100A4 in endothelial cells is involved in tube formation, and suggest its potential as a molecular target for inhibiting tumor angiogenesis
S100A4 is overexpressed in an experimental head and neck squamous cell carcinoma, and its inhibition reduces tumor burden.
interaction of macrophage-derived S100A4 with B16-F10 (show F10 Antibodies) melanoma results in increased metastatic lung colonization in vivo
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified.
S100 calcium binding protein A4
, S100 calcium-binding protein A4
, S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, fibroblast-specific protein-1
, leukemia multidrug resistance associated protein
, malignant transformation suppression 1
, placental calcium-binding protein
, protein Mts1
, protein S100-A4
, S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)
, S100 calcium-binding protein A4 (calcium protein,calvasculin, metastasin, murine placental homolog)
, placental calcium-binding protein homolog
, metastatic cell protein
, protein 18A2
, Protein 9 Ka homologous to calcium-binding protein
, nerve growth factor-induced protein 42A